Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT06863233

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-08-12

5

Participants Needed

7

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study to learn whether PET/CT (positron emission tomography/computed tomography) scans using an imaging agent (radiotracer) called zirconium Zr 89 crefmirlimab berdoxam is a safe and effective way to identify CD8+ T cells

CONDITIONS

Official Title

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient must be 18 years of age or older at the time of signing the informed consent.
  • Patient has a histologically confirmed diagnosis of metastatic non-small cell lung cancer.
  • Patient is enrolled in the engineered TIL cell therapy protocol OBX115-23-01, but has not received the treatment yet.
  • Men and women of child-producing potential must use effective double barrier contraceptive methods during the study and up to 30 days after the last administration of the investigational product.
  • Patient or legally authorized representative provided signed informed consent, including compliance with study requirements.
  • Patient or legally authorized representative provided written authorization for use and disclosure of protected health information.
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women.
  • Patients with a history of splenectomy or significant splenic dysfunction, such as splenomegaly or recurrent infections due to impaired immune function.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Memorial Sloan Kettering at Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering Westchester (Consent only)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering Cancer Center (All protocol activities)

New York, New York, United States, 10065

Actively Recruiting

7

Memorial Sloan Kettering Cancer Center @ Nassau (Consent only)

Uniondale, New York, United States, 11553

Actively Recruiting

Loading map...

Research Team

A

Adam Schoenfeld, MD

CONTACT

A

Alexander Shoushtari, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here